Arkolith/Insider Trading/ATOS/Form 4

Weaver Gregory L

Former EVP, CFO, & Director, DirectorATOSSA THERAPEUTICS, INC. (ATOS) · full profile →Form 4 · filed Nov 17, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$33K
Net Open-Market Flow
-$33K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2023Sell(S)50K$0.65$33K55

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-032461) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML